- Home
- TRAK vs MIST Comparison
TRAK vs MIST Comparison
Compare TRAK & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRAK | MIST |
|---|---|---|
| Founded | 1990 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.2M | 176.3M |
| IPO Year | 1996 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TRAK | MIST |
|---|---|---|
| Price | $10.44 | $1.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 101.7K | ★ 1.4M |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | ★ 0.90% | N/A |
| EPS Growth | ★ 20.69 | N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $21,007,076.00 | N/A |
| Revenue This Year | $6.61 | $2,915.14 |
| Revenue Next Year | $10.04 | N/A |
| P/E Ratio | $36.82 | ★ N/A |
| Revenue Growth | ★ 4.84 | N/A |
| 52 Week Low | $6.94 | $1.00 |
| 52 Week High | $22.17 | $3.06 |
Technical Indicators
Market Signals| Indicator | TRAK | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 62.93 | 34.70 |
| Support Level | $10.03 | $1.00 |
| Resistance Level | $10.64 | $2.30 |
| Average True Range (ATR) | 0.46 | 0.11 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 83.33 | 5.17 |
Price Performance
Historical ComparisonAbout TRAK ReposiTrak Inc.
ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).